Home / News /

Semiotik LLC and GlycoTech Corporation (USA) concluded an agreement on distribution

12.05.2015 Semiotik LLC and GlycoTech Corporation (USA) concluded an agreement on distribution of the product of LLC Semiotik, a research microchip for quantification of glycan-binding proteins,in North America. Detection of glycan-specific antibodies in blood opens the way to diagnostics of a wide range of infectious, autoimmune and oncological diseases. Mapping of specificity of bacterial and viral lectins and phage glycanases is the key stage in development of antimicrobial drug products of new generation,which are an alternative to classic antibiotics.
GlycoTech Corporation (USA) was founded in 1991; company is the key supplier of reagents for glycobiological studies in USA. The company performs active in-house studies in the field of the search of new glycotherapeutics and works as a partner for pharmaceutical companies and centers in the USA.